Edition:
United States

Ankur Banerjee

Pfizer, J&J urge clarity from FDA on future of COVID-19 vaccine trials once a vaccine is available

Oct 22 2020

Pfizer Inc and Johnson & Johnson are seeking input from a U.S. Food and Drug Administration advisory committee on retaining and attracting volunteers for COVID-19 vaccine trials after a vaccine becomes available, if they know they might receive a placebo.

Bausch Health to spin off eye care business, shares soar

Aug 06 2020

Canadian drugmaker Bausch Health Companies Inc said on Thursday it would spin off its eye care unit, Bausch + Lomb, into a separate publicly listed company, seven years after acquiring it for nearly $9 billion.

Moderna prices COVID-19 vaccine at $32-$37 per dose for smaller volume deals

Aug 05 2020

Moderna Inc said on Wednesday smaller volume agreements for its experimental coronavirus vaccine have been priced in the range of $32 to $37 per dose, higher than the price set by the U.S. deal for Pfizer Inc's vaccine candidate.

Proportion of youth with COVID-19 triples in five months: WHO

Aug 04 2020

Young people who are hitting nightclubs and beaches are leading a rise in fresh coronavirus cases across the world, with the proportion of those aged 15 to 24 who are infected rising three-fold in about five months, the World Health Organization said.

U.S. drugmaker earnings heat up this week with spotlight on vaccine news

Jul 27 2020

Several major U.S. drugmakers will report second-quarter results this week, with investors eager for fresh details from Pfizer Inc , Merck & Co and others on their efforts to develop vaccines and therapies against the novel coronavirus.

U.S. to pay Pfizer, BioNTech $1.95 billion for COVID-19 vaccine

Jul 22 2020

The U.S. government will pay nearly $2 billion to buy enough of a COVID-19 vaccine being developed by Pfizer Inc and German biotech BioNTech SE to innoculate 50 million people if it proves to be safe and effective, the companies said on Wednesday. | Video

CORRECTED-UPDATE 5-U.S. to pay Pfizer, BioNTech $1.95 bln for 100 million COVID-19 vaccine doses

Jul 22 2020

July 22 The U.S. government will pay $1.95 billion to buy 100 million doses of a COVID-19 vaccine being developed by Pfizer Inc and German biotech BioNTech SE if it proves to be safe and effective, the companies said on Wednesday.

CanSino coronavirus vaccine shows immune response in human trial

Jul 20 2020

A vaccine against the coronavirus developed by CanSino Biologics Inc and China's military research unit appears to be safe and induced immune responses in most subjects in a closely-watched mid-stage study, researchers said on Monday.

World News